COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced that it has ...

COMPASS Pathways’ CEO, Kabir Nath, has a clear vision for psychedelics—and is leading the way with the company’s focus on psilocybin and efforts to separate the science from the hype. When the English ...

COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced that it has appointed ...

Q2 2025 Management View Kabir Kumar Nath, CEO, announced the appointment of Justin Gover, former CEO of GW Pharmaceuticals, to the Board of Directors, highlighting his experience with "Epidiolex, the ...

LONDON/NEW YORK - Biotechnology company Compass Pathways plc (NASDAQ:CMPS) announced Tuesday the appointment of Justin Gover to its Board of Directors, effective immediately, as the company prepares ...

Boost for Mental Health Medicines R&D as COMPASS Pathways Joins the Psychiatry Consortium Global mental health care company, COMPASS Pathways plc has joined the Psychiatry Consortium, bringing ...

Global mental health care company, COMPASS Pathways plc has joined the Psychiatry Consortium, bringing additional expertise and insights to the group. A company dedicated to accelerating patient ...

Compass Pathways is advancing clinical trials for COM360, with data from the COMM-five trial expected soon. The company plans to leverage SPRAVATO’s infrastructure for COM360’s commercialization.

LONDON, April 27, 2020 /PRNewswire/ -- COMPASS Pathways, a mental health care company, announced today that it has completed a successful $80m Series B investment round. This funding will expand upon ...

LONDON, June 23, 2020 /PRNewswire/ -- COMPASS Pathways, a mental health care company, announced today that it has made a number of new appointments to its leadership team. Trevor Mill joins the ...